posted on 2020-07-06, 13:33authored byLimor Cohen, Naiwen Cui, Yamei Cai, Padric M. Garden, Xiang Li, David A. Weitz, David R. Walt
Many
proteins are present at low concentrations in biological samples,
and therefore, techniques for ultrasensitive protein detection are
necessary. To overcome challenges with sensitivity, the digital enzyme-linked
immunosorbent assay (ELISA) was developed, which is 1000× more
sensitive than conventional ELISA and allows sub-femtomolar protein
detection. However, this sensitivity is still not sufficient to measure
many proteins in various biological samples, thereby limiting our
ability to detect and discover biomarkers. To overcome this limitation,
we developed droplet digital ELISA (ddELISA), a simple approach for
detecting low protein levels using digital ELISA and droplet microfluidics.
ddELISA achieves maximal sensitivity by improving the sampling efficiency
and counting more target molecules. ddELISA can detect proteins in
the low attomolar range and is up to 25-fold more sensitive than digital
ELISA using Single Molecule Arrays (Simoa), the current gold standard
tool for ultrasensitive protein detection. Using ddELISA, we measured
the LINE1/ORF1 protein, a potential cancer biomarker that has not
been previously measured in serum. Additionally, due to the simplicity
of our device design, ddELISA is promising for point-of-care applications.
Thus, ddELISA will facilitate the discovery of biomarkers that have
never been measured before for various clinical applications.